Webinar Date/Time: Tue, Mar 4, 2025 11:00 AM EST
See how the Oceo Rover can transform your media hydration. This is your opportunity to adopt game-changing single-use technology that fast tracks therapies to patients in need. Learn about revolutionary bioprocessing technology that hydrates media in half the time of conventional processes.
Register Free: https://www.biopharminternational.com/bp_w/media-hydration
Event Overview:
Transform bioprocessing operations with the Oceo Rover automated hydration system. Designed specifically for the hydration of powdered media, feeds, or buffers, this single use system delivers consistent solutions on demand in less than half the time of conventional processes. The Oceo Rover supports both FUJIFILM Irvine Scientific media formulations and custom media platforms for various modalities in both upstream and downstream environments. This program will provide insights into how the Oceo Rover offers comprehensive bioprocessing solutions for both process development and manufacturing across a wide range of scales.
Join us to Discover:
Who Should Attend:
Speaker:
Guy Matthews
Director, Market Development Single-Use Technology
FUJIFILM
Guy Matthews is the director of market development single-use technology, FUJIFILM Irvine Scientific. Matthews has worked in the biopharmaceutical industry all his career, and has seen the implementation of single-use technologies from the very beginning. He started out as a microbiologist at a CMO in the United Kingdom before moving into more commercial roles. Matthews has experience in both upstream and downstream processing with the focus on the application of single-use technology.
Register Free: https://www.biopharminternational.com/bp_w/media-hydration
Biotech EG 427 Raises €27 Million in Series B Funding to Advance Lead Genetic Medicine Candidate
February 24th 2025Co-led by Andera Partners and Bpifrance, the Series B financing will go toward an ongoing Phase Ib/IIa clinical study for EG 427’s lead candidate and to advance the company’s genetic medicines platform.